Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Yuki, Hiroshima"'
Autor:
Satomi Nagaya, Keiko Maruyama, Atsushi Watanabe, Makiko Meguro-Horike, Yuta Imai, Yuki Hiroshima, Shin-Ichi Horike, Koichi Kokame, Eriko Morishita
Publikováno v:
Haematologica, Vol 107, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/f0fd39888020408c91969eb4679fbda9
Autor:
Mari Kitahara, Masahiko Sumi, Hiroko Kazumoto, Tsutomu Shishido, Toshimitsu Ueki, Yuki Hiroshima, Katsuhiko Kamei, Hikaru Kobayashi
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 10, p1465-1471, 7p
Autor:
Keijiro Sato, Hidetoshi Satomi, Toshimitsu Ueki, Hikaru Kobayashi, Mayumi Ueno, Yuki Hiroshima, Naoaki Ichikawa, Masahiko Sumi
Publikováno v:
Internal Medicine. 61:1225-1230
Two adult patients with acute leukemia developed transplantation-associated microangiopathy (TAM) related to graft-versus-host disease (GVHD). Both patients were resistant to standard therapy for TAM and GVHD, which led to markedly elevated serum tot
Autor:
Makiko Meguro-Horike, Koichi Kokame, Eriko Morishita, Satomi Nagaya, Shin-ichi Horike, Yuta Imai, Keiko Maruyama, Yuki Hiroshima, Atsushi Watanabe
Publikováno v:
Haematologica. 107:330-333
Autor:
Keijiro, Sato, Masahiko, Sumi, Masafumi, Maruyama, Hiroko, Kaiume, Toshimitsu, Ueki, Yuki, Hiroshima, Ichiro, Ito, Hikaru, Kobayashi
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(10)
A 46-year-old man with myelodysplastic syndrome/myeloproliferative neoplasm-unclassifiable underwent myeloablative bone marrow transplantation from an HLA-DR-1-antigen-mismatched related donor while receiving tacrolimus and mycophenolate mofetil (MMF
Autor:
Toshimitsu Ueki, Fumio Shiratori, Taro Nakajima, Hikaru Kobayashi, Yuki Hiroshima, Takayoshi Tokutake, Masahiko Sumi, Shohei Nakata
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 67:27-32
Autor:
Takayoshi Tokutake, Hisami Baba, Yuji Shimada, Wataru Takeda, Keijiro Sato, Yuki Hiroshima, Takehiko Kirihara, Ikuo Shimizu, Hideyuki Nakazawa, Hikaru Kobayashi, Fumihiro Ishida
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157835 (2016)
The activated partial thromboplastin time (APTT) assay is a basic hemostatic assay based on the time it takes for clots to form in plasma samples after the addition of calcium chloride. It is used to screen for various coagulation disorders. Several
Externí odkaz:
https://doaj.org/article/2996f4bef68144ce93c63769d687ec00
Autor:
Hikaru Kobayashi, Yuki Hiroshima, Keijiro Sato, Masahiko Sumi, Toshimitsu Ueki, Hiroko Kazumoto, Nozomu Uematsu, Tsutomu Shishido, Mari Kitahara, Takehiko Kirihara
Publikováno v:
Internal Medicine
We present the case of a 53-year-old woman with prefibrotic stage primary myelofibrosis (PMF) who underwent cord blood transplantation. Nine years after transplantation, she relapsed, which was confirmed by a bone marrow examination. We decided to tr
Autor:
Takehiko Kirihara, Hiroko Kazumoto, Kunihiko Shimizu, Masahiko Sumi, Mari Kitahara, Yuki Hiroshima, Hikaru Kobayashi, Keijiro Sato, Nozomu Uematsu, Toshimitsu Ueki, Tsutomu Shishido
Publikováno v:
Internal Medicine
A 51-year-old woman with Philadelphia chromosome-positive acute lymphoblastic leukemia underwent a second cord blood transplantation followed by maintenance therapy with interferon-α. After 33 months, she developed cardiogenic shock caused by advanc
Autor:
Masahiko Sumi, Hidetoshi Satomi, Mari Kitahara, Hiroko Kazumoto, Tsutomu Shishido, Hiroko Kaiume, Keijiro Sato, Toshimitsu Ueki, Yuki Hiroshima, Ichiro Ito, Hikaru Kobayashi
Publikováno v:
Clinical lymphoma, myelomaleukemia. 22(7)
CBT with ATG use is a well-known PTLD risk factor. However, little is known regarding the clinical features of PTLD after ATG-free CBT.We analyzed the incidence, risk factors and prognosis of PTLD in 183 adults undergoing ATG-free CBT.Fifteen patient